| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunovant, Inc. | Chief Legal Officer | Common Stock | 319K | $8.12M | $25.45 | 20 Nov 2024 | Direct |
| Immunovant, Inc. | Chief Legal Officer | Stock Option (right to buy) | 68.7K | 02 Apr 2024 | Direct | ||
| Flexion Therapeutics Inc | General Counsel | Common Stock | 0 | $8.50 | 19 Nov 2021 | Direct | |
| Flexion Therapeutics Inc | General Counsel | Stock Option (right to buy) | 0 | 19 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | 20 Nov 2024 | 1 | -$92.9K | 4 | Chief Legal Officer | 22 Nov 2024, 16:12 |
| IMVT | Immunovant, Inc. | 23 Oct 2024 | 1 | -$129K | 4 | Chief Legal Officer | 25 Oct 2024, 16:25 |
| IMVT | Immunovant, Inc. | 16 Oct 2024 | 1 | -$82.3K | 4 | Chief Legal Officer | 18 Oct 2024, 16:28 |
| IMVT | Immunovant, Inc. | 21 Aug 2024 | 2 | -$105K | 4 | Chief Legal Officer | 23 Aug 2024, 16:15 |
| IMVT | Immunovant, Inc. | 24 Jul 2024 | 1 | -$111K | 4 | Chief Legal Officer | 26 Jul 2024, 16:17 |
| IMVT | Immunovant, Inc. | 17 Jul 2024 | 2 | -$74.4K | 4 | Chief Legal Officer | 19 Jul 2024, 17:42 |
| IMVT | Immunovant, Inc. | 22 May 2024 | 1 | -$96.1K | 4 | Chief Legal Officer | 24 May 2024, 16:10 |
| IMVT | Immunovant, Inc. | 24 Apr 2024 | 1 | -$115K | 4 | Chief Legal Officer | 26 Apr 2024, 17:18 |
| IMVT | Immunovant, Inc. | 17 Apr 2024 | 2 | -$286K | 4 | Chief Legal Officer | 19 Apr 2024, 18:06 |
| IMVT | Immunovant, Inc. | 02 Apr 2024 | 2 | $0 | 4 | Chief Legal Officer | 04 Apr 2024, 16:37 |
| IMVT | Immunovant, Inc. | 22 Feb 2024 | 1 | -$77.1K | 4 | Chief Legal Officer | 23 Feb 2024, 16:18 |
| IMVT | Immunovant, Inc. | 26 Jan 2024 | 2 | -$115K | 4 | Chief Legal Officer | 29 Jan 2024, 16:12 |
| IMVT | Immunovant, Inc. | 22 Nov 2023 | 2 | -$107K | 4 | Chief Legal Officer | 24 Nov 2023, 14:41 |
| IMVT | Immunovant, Inc. | 25 Oct 2023 | 1 | -$142K | 4 | Chief Legal Officer | 27 Oct 2023, 16:04 |
| IMVT | Immunovant, Inc. | 24 Aug 2023 | 2 | -$249K | 4 | Chief Legal Officer | 25 Aug 2023, 18:05 |
| IMVT | Immunovant, Inc. | 26 Jul 2023 | 1 | -$84.7K | 4 | Chief Legal Officer | 27 Jul 2023, 16:33 |
| IMVT | Immunovant, Inc. | 25 Apr 2023 | 1 | -$42.9K | 4 | Chief Legal Officer | 26 Apr 2023, 16:08 |
| IMVT | Immunovant, Inc. | 12 Apr 2023 | 2 | $0 | 4 | Chief Legal Officer | 14 Apr 2023, 16:24 |
| IMVT | Immunovant, Inc. | 26 Jan 2023 | 1 | -$188K | 4 | Chief Legal Officer | 27 Jan 2023, 06:20 |
| IMVT | Immunovant, Inc. | 17 Aug 2022 | 2 | $0 | 4 | Chief Legal Officer | 19 Aug 2022, 16:57 |
| IMVT | Immunovant, Inc. | 28 Jan 2022 | 2 | $0 | 4 | Chief Legal Officer | 31 Jan 2022, 16:01 |
| IMVT | Immunovant, Inc. | 19 Jan 2022 | 0 | $0 | 3 | Chief Legal Officer | 28 Jan 2022, 06:14 |
| FLXN | Flexion Therapeutics Inc | 19 Nov 2021 | 6 | -$1.13M | 4 | General Counsel | 19 Nov 2021, 09:08 |
| FLXN | Flexion Therapeutics Inc | 19 Jul 2021 | 1 | -$25.4K | 4 | General Counsel | 20 Jul 2021, 20:45 |